SAN FRANCISCO, July 23, 2026 /PRNewswire/ -- National shareholder rights firm Hagens Berman (HBSS) is investigating potential violations of U.S. securities laws by Alignment Healthcare, Inc. (NASDAQ: ALHC) following reports of a whistleblower lawsuit alleging systemic financial manipulation.
SUBMIT YOUR ALHC INVESTMENT LOSSES TO HBSS
Visit: www.hbsslaw.com/investor-fraud/alhc
Contact the Firm Now: [email protected]
844-916-0895
Alignment Healthcare, Inc. (ALHC) Investigation:
On July 8, 2026, news broke that a former Alignment Healthcare executive had filed a lawsuit alleging the company engaged in deliberate accounting irregularities to inflate its financial results.
The whistleblower, Hakan Kardes, who was employed by Alignment from 2019 to 2025 and most recently served as the company's chief transformation officer, alleges that Alignment misclassified operating expenses as capital expenditures. These actions purportedly boosted the company's adjusted Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) for 2024 and 2025, thereby artificially inflating key performance metrics tied to both the company's stock price and executive compensation.
This revelation comes shortly after Alignment Healthcare had aggressively touted strong first-quarter 2026 financial results—including significant revenue growth, a swing to profitability, and raised full-year guidance—which had driven the company's share price toward 52-week highs.
Following the disclosure of...
The US Court of Appeals for the Tenth Circuit affirmed in part and reversed in part the dismissal of a false advertising complaint, clarifying that courts must take a “holistic” approach when dete...